cover image - Brenner and Stevens’ Pharmacology - Elsevier eBook on VitalSource, 7th Edition
ISBN: 9780443436833
Copyright: 2028
Page Count: 624
Imprint: Elsevier
List Price: $75.99

Brenner and Stevens’ Pharmacology - Elsevier eBook on VitalSource, 7th Edition

by Craig W. Stevens, PhD and Kelly Murray, PharmD

Elsevier eBook on VitalSource

cover image - Brenner and Stevens’ Pharmacology - Elsevier eBook on VitalSource, 7th Edition
ISBN: 9780443436833
Copyright: 2028
Page Count: 624
Imprint: Elsevier
List Price: $75.99
Not Yet Available
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.
Coming Soon!
Expected availability date: 04-08-2027
Important note
You are viewing the faculty version.
Students requesting access will be reported.
Designed to take students from course exams right through to clinical practice, Brenner and Stevens’ Pharmacology, 7th Edition, delivers the essential principles readers need to know without overwhelming them with extraneous information. Craig W. Stevens, PhD, along with new coauthor Kelly A. Murray, PharmD, use a succinct, reader-friendly writing style and provide hundreds of detailed illustrations that make complex concepts easier to understand. New and extensively revised content keeps students up to date with the latest pharmacologic mechanisms and applications.
    • Helps students learn and retain key information in pharmacology with abundant full-color illustrations, concise yet detailed explanations, and a consistent format that clearly presents drug classifications for each system and disease
    • Teaches both the basic science foundations and clinical applications of pharmacology, with useful tables, drug classifications boxes, case studies, and self-assessment questions in each chapter to help students review and prepare for course exams
    • Includes updated drug lists and therapeutic indications along with updates to each chapter
    • Addresses emerging, innovative topics such as mRNA vaccines, monoclonal antibody drugs, and gene techniques such as antisense mRNA, CRISPR, and other recent developments
    • Features new and revised figures that clearly present the mechanism of action of drug molecules and their receptors
    • Provides exclusive online access to animations, an additional glossary, chapter-by-chapter summaries and case studies, a comprehensive list of featured drugs, 150 USMLE-style self-assessment questions, and more
    • An eBook version is included with purchase. The eBook allows access to all of the text and figures, with the ability to search, make notes and highlights, and have content read aloud
  • Section I PRINCIPLES OF PHARMACOLOGY
    1. Introduction to Pharmacology and Drug Names
    2. Pharmacokinetics or What the Body Does to the Drug
    3. Pharmacodynamics or What the Drug Does to the Body
    4. Drug Development and Drug Safety 35
    5. Toxicology Principles and the Treatment of Poisoning

    Section II AUTONOMIC AND NEUROMUSCULAR PHARMACOLOGY
    6. Parasympathetic, Neuromuscular Pharmacology, and Cholinergic Agonists
    7. Cholinergic Receptor Antagonists
    8. Sympathetic Neuropharmacology and Adrenergic Agonists
    9. Adrenergic Receptor Antagonists

    Section III CARDIOVASCULAR, RENAL, AND HEMATOLOGIC PHARMACOLOGY
    10. Antihypertensive Drugs
    11. Antianginal Drugs
    12. Drugs for the Treatment of Heart Failure
    13. Diuretic Drugs
    14. Drugs for Cardiac Dysrhythmia
    15. Drugs for Hyperlipidemia
    16. Antithrombotic and Thrombolytic Drugs
    17. Hematopoietic Drugs

    Section IV CENTRAL NERVOUS SYSTEM PHARMACOLOGY
    18. Introduction to Central Nervous System Pharmacology
    19. Sedative-Hypnotic and Anxiolytic Drugs
    20. Antiepileptic Drugs
    21. Local and General Anesthetics
    22. Psychotherapeutic Drugs
    23. Opioid Analgesics and Antagonists
    24. Drugs for Neurodegenerative Diseases
    25. Drugs of Abuse Section

    V PHARMACOLOGY OF RESPIRATORY AND OTHER SYSTEMS
    26. Autacoid Drugs That Mimic Endogenous Substances
    27. Pharmacological Treatment of Respiratory Disorders
    28. Pharmacological Treatment of Gastrointestinal Disorders
    29. Drugs for Headache Disorders
    30. Drugs for Pain, Inflammation, and Arthritic Disorders Section

    VI ENDOCRINE PHARMACOLOGY
    31. Hypothalamic and Pituitary Hormone Drugs
    32. Drugs for the Treatment of Thyroid Disorders
    33. Adrenal Steroids and Related Drugs
    34. Fertility and Reproduction Drugs
    35. Drugs for the Treatment of Diabetes
    36. Drugs Affecting Calcium and Bone Formation Section

    VII ANTIMICROBIAL AND CHEMOTHERAPEUTIC AGENTS
    37. Principles of Antimicrobial Chemotherapy
    38. Antibiotics That Inhibit Bacterial Cell Wall Synthesis
    39. Antibiotics That Inhibit Bacterial Protein Synthesis
    40. Other Antimicrobial Agents Such as Quinolones and Antifolate Drugs
    41. Antimycobacterial Drugs for Treating Tuberculosis and Other Diseases
    42. Drugs for the Treatment of Fungal Infections
    43. Drugs for the Treatment of Viral Infections
    44. Drugs for the Treatment of Parasites
    45. Antineoplastic Agents
    46. Immunopharmacology, Biologicals, and Gene Therapy Answers and Explanations Index
  • Craig W. Stevens, PhD, Professor of Pharmacology, Department of Pharmacology and Physiology, Oklahoma State University-Center for Health Sciences, Tulsa, OK, USA and Kelly Murray, PharmD, Clinical Professor of Clinical Pharmacy, Department of Emergency Medicine OSU Center for Health Sciences, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
    • Conformance
      • The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
      • For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
      • For queries regarding accessibility information, contact [email protected]
      • The publication was certified on 17-12-2025
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Not Yet Available
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.
Coming Soon!
Expected availability date: 04-08-2027
Important note
You are viewing the faculty version.
Students requesting access will be reported.